GLP-1 Peptides and Glaucoma Risk: What We Know and What to Watch
A nationwide Danish registry study also found that GLP-1 agonist use was linked to a lower glaucoma risk. Compared to diabetic patients on other...
Liraglutide
Deep research and expert guides on maintaining your visual health.
Free Online Peripheral Vision Screening
Our visual field test is inspired by the perimetry methods eye care professionals use. Check for blind spots and track changes over time.
Test Your Visionliraglutide
Liraglutide is another medicine in the GLP-1 receptor agonist group that is given as a daily injection. It is used to improve blood sugar control in people with type 2 diabetes and, at higher doses, to support weight loss in people with obesity. Liraglutide works by increasing insulin release when blood sugar is high, slowing gastric emptying, and helping reduce hunger, which can lead to lower calorie intake. Common side effects include nausea, vomiting, diarrhea, and sometimes constipation, with many people finding these lessen over time. More serious but uncommon risks include pancreatitis and gallbladder disease, and there are specific safety warnings for people with a family history of certain types of thyroid cancer based on animal studies. When liraglutide is used with other diabetes medicines that can cause low blood sugar, doses may need to be adjusted to avoid hypoglycemia. Because it affects appetite and digestion, it can also change how other oral medicines are absorbed, so doctors will review other prescriptions. Liraglutide can be an effective part of diabetes and weight management plans, but it should be started and monitored under medical supervision to balance benefits and risks.